All
April 4, 2014

Controlling Compliance Risk in Global Clinical Research Activities

Pharmaceutical Compliance Monitor

By Daniel A. Kracov Mahnu V. Davar
Find more content tagged:

People

Daniel A. Kracov

Daniel A. Kracov

Partner
Washington, DC
+1 202.942.5120
Mahnu V. Davar

Mahnu V. Davar

Partner
Washington, DC
+1 202.942.6172

Related Content

August 8, 2022
FDA Issues Draft Guidance Addressing Remote Regulatory Assessments
Advisory
July 27, 2022
EU Commission Adopts Proposal for a Regulation on Substances of Human Origin
BioSlice Blog
July 25, 2022
Relaxed Regulations Leads to a Surge in Telehealth Use . . . and a Surge of Enforcement
Advisory
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept